| Event Start Date: June 4, 2026 | Event End Date: June 4, 2026 | Event Venue: |
JBI gLOCAL Solution Room
Evidence on Prevention, Screening, and Management of Cervical Cancer
07:00 – 13:15 Ghana
09:00 – 15:15 South Africa
12:30 – 18:30 India
09:00 – 15:15 South Africa
12:30 – 18:30 India
The JBI gLOCAL Solution Room is a week-long global series of locally hosted, interactive events designed to provide pragmatic solutions to challenges in getting evidence into practice, bringing together clinicians, academics and policymakers to discuss how global evidence informs local practice and how local experience shapes global thinking in evidence-based healthcare. JBI explicitly frames “gLOCALization” as the simultaneous global and local nature of evidence generation, synthesis, transfer and implementation, emphasizing that evidence must be adapted to specific contexts given differences in economics, policy, systems and culture.
Despite remarkable advances in medical science, far too many lives are still lost each year due to gaps in awareness, access to vaccination, screening, and timely treatment. This gLOCAL solution provides a vital platform for sharing knowledge, strengthening collaboration, and renewing our collective commitment to ensuring that no woman dies from a disease we have the tools to prevent and cure. This gLOCAL solution focuses on the importance of eliminating cervical cancer, a disease that remains a significant yet largely preventable threat to women’s health worldwide.
JBI Evidence-Based Indigenous Health India
JBI Ekurhuleni Clinical Research Centre, South Africa
JBI Evidence-Based Practice Research Group Ghana
08:30 – 09:00
Arrival & Registration
1
Session 1: Introduction and Overview
Session Chair: Dr Sajda Khatoon (India)
| Time (GH / SA / IN) | Talk | Country |
|---|---|---|
| 07:00–07:10 GH 09:00–09:10 SA 12:30–12:40 IN |
Welcome and Introduction
Dr Sajda Khatoon
|
India |
| 07:10–07:40 GH 09:10–09:40 SA 12:40–13:10 IN |
Introduction to JBI
Prof Zoe Jordan — JBIC, Adelaide, Australia
|
Australia |
| 07:40–08:05 GH 09:40–10:05 SA 13:10–13:35 IN |
Introduction to JBI directors
JBI Centre Directors — South Africa, India, Cameroon & Ghana
|
Multi |
| 08:05–08:30 GH 10:05–10:30 SA 13:35–14:00 IN |
Keynote Speaker: Guideline on cervical cancer screening for HIV patients Keynote
Professor Greta Dreyer — University of Pretoria, South Africa; President, International Gynecologic Cancer Society
|
South Africa |
2
Session 2: Screening to Treatment — Integrated Approaches to Cervical Cancer Prevention
Session Chairs: Dr Bernard Uzabakiriho (South Africa) & Dr Krishantha Pillay (South Africa)
| Time (GH / SA / IN) | Talk | Country |
|---|---|---|
| 08:30–08:45 GH 10:30–10:45 SA 14:00–14:15 IN |
Prevention & Early detection of HPV lesions: HPV Screen-And-Treat (SAT) with Point of Care testing, same-day results and treatment
Dr KK Khulu — University of the Witwatersrand
|
South Africa |
| 08:45–09:00 GH 10:45–11:00 SA 14:15–14:30 IN |
HPV Testing vs Cytology: Evidence for Primary Screening
Prof Matthys Cornelis van Aardt — University of Pretoria
|
South Africa |
| 09:00–09:15 GH 11:00–11:15 SA 14:30–14:45 IN |
Eliminating cervical cancer in Ghana: Aligning national prevention efforts with global elimination targets
Prof Edward Tieru Dassah — Kwame Nkrumah University of Science and Technology
|
Ghana |
| 09:15–09:30 GH 11:15–11:30 SA 14:45–15:00 IN |
Management of Precancerous Lesions — LLETZ: safety issues, post-LLETZ management, management of complications
Dr E Mnisi — University of Pretoria
|
South Africa |
| 09:30–09:45 GH 11:30–11:45 SA 15:00–15:15 IN |
Perceptions and Practices relating to the Human Papilloma Virus among caregivers and adolescents: Implication for HPV vaccine acceptance
Dr Asahngwa Constantine — University of Yaoundé 1, Cameroon
|
Cameroon |
| 09:45–10:00 GH 11:45–12:00 SA 15:15–15:30 IN | Q & A — Session chairs |
— Health break: 15 minutes —
3
Session 3: Treatment Challenges and Innovative Approaches for Managing Complexity of Cervical Cancer Care
Session Chairs: Dr Raj Shankar Ghosh (India) & Prof Yeetey Enuameh (Ghana)
| Time (GH / SA / IN) | Talk | Country |
|---|---|---|
| 10:15–10:30 GH 12:15–12:30 SA 15:45–16:00 IN |
Radiotherapy treatment resistance in cervical cancer
Prof Shenaaz Bassa — University of Pretoria
|
South Africa |
| 10:30–10:45 GH 12:30–12:45 SA 16:00–16:15 IN |
Cervical Cancer in Pregnant WLHIV: Case series
Dr B. Uzabakiriho — University of the Witwatersrand
|
South Africa |
| 10:45–11:00 GH 12:45–13:00 SA 16:15–16:30 IN |
Role of telemedicine for management of cervical cancer
Dr Krishantha Pillay — University of Pretoria
|
South Africa |
| 11:00–11:15 GH 13:00–13:15 SA 16:30–16:45 IN |
India's Journey in Cervical Cancer Care: Integrating Prevention, Screening, and Treatment
Dr Raj Shankar Ghosh
|
India |
| 11:15–11:30 GH 13:15–13:30 SA 16:45–17:00 IN | Q & A — Session chairs |
— Health break: 15 minutes —
4
Session 4: Role of Data, Surveillance, and Health Communication for Strengthening Control of Cervical Cancer
Session Chair: Prof Shenaaz Bassa (South Africa)
| Time (GH / SA / IN) | Talk | Country |
|---|---|---|
| 11:45–12:00 GH 13:45–14:00 SA 17:15–17:30 IN |
Role of Cancer registry for management of cervical cancer
Dr Mazvita Muchengeti — South African National Cancer Registry
|
South Africa |
| 12:00–12:15 GH 14:00–14:15 SA 17:30–17:45 IN |
Surveillance of cervical cancer in a central hospital in South Africa
Dr Nozipho Magagula — University of Pretoria
|
South Africa |
| 12:15–12:30 GH 14:15–14:30 SA 17:45–18:00 IN |
Health communication in cervical cancer
Dr Kaushik Ghosh — Fellow, CPHR
|
India |
| 12:30–12:45 GH 14:30–14:45 SA 18:00–18:15 IN | Q & A — Session chair | |
| 12:45–13:15 GH 14:45–15:15 SA 18:15–18:30 IN |
Way forward & closure
Dr Paramita Bhattacharya
|
India |